Edition 4 of the IMDRF’s Non-In Vitro Diagnostic Device Market Authorization Table of Contents (nIVD MA ToC) introduces a clearer, modular blueprint for medical-device dossiers, distinguishing universal core material from region-specific requirements and supplying a matrix that flags which sections are required, optional or conditional—especially for the EU. The white paper argues that this harmonized format can cut duplication and speed multi-country approvals, yet warns that manufacturers must master its granular taxonomy, stay alert to continual updates, and manage technical hurdles such as file naming and size limits; it also excludes combination products, which still need separate pathways. To navigate these challenges, the authors recommend targeted staff training, help from regulatory specialists, software to automate document architecture, and small-scale pilot filings. Employed wisely, the nIVD MA ToC is portrayed as an evolving tool that boosts transparency, efficiency and ultimately faster global market access for medical devices.
